ArticleJournal of cutaneous pathology2026
Multicentric Reticulohistiocytosis Induced Alopecia: A Clinical Case Report.
Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multicentric Reticulohistiocytosis Induced Alopecia: A Clinical Case Report.Journal of cutaneous pathology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multicentric reticulohistiocytosis (MRH) is a systemic inflammatory disease with dermatologic, musculoskeletal, and mucosal manifestations with symmetric erosive arthritis and reddish-brown papulonodular lesions. Histopathologic findings include epithelioid and multinucleated histiocytes with ground glass cytoplasm. We demonstrate the case of a 52-year-old female who presented with scattered red-brown papules, finger swelling, and muscle pain. Biopsy demonstrated a dermal proliferation of large mononucleated and multinucleated histiocytes with dense, pink, oncocytic cytoplasm, consistent with MRH. Patient initiated prednisone, methotrexate, folic acid, and adalimumab. On follow-up, the patient reported progressive hair loss confined to the frontal scalp. Physical exam showed moderately well-defined, pauci-inflammatory alopecic patches with follicular drop-out and negative hair pull test. A punch biopsy from the scalp demonstrated a marked decrease in follicular units associated with aggregates of histiocytes in the upper dermis with infiltration of the follicular epithelium, some multinucleate, with abundant two-toned ground-glass cytoplasm. A diagnosis of alopecia secondary to follicular involvement by reticulohistiocytosis was made. To our knowledge, this is the first reported case of alopecia secondary to MRH in the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.